1. Home
  2. TTEK vs KRYS Comparison

TTEK vs KRYS Comparison

Compare TTEK & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

N/A

Current Price

$33.72

Market Cap

9.5B

ML Signal

N/A

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$325.31

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTEK
KRYS
Founded
1966
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
9.6B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
TTEK
KRYS
Price
$33.72
$325.31
Analyst Decision
Buy
Strong Buy
Analyst Count
8
12
Target Price
$40.33
★ $392.11
AVG Volume (30 Days)
★ 1.7M
204.3K
Earning Date
11-11-2026
11-02-2026
Dividend Yield
★ 0.87%
N/A
EPS Growth
N/A
★ 128.00
EPS
1.18
★ 3.62
Revenue
★ $2,964,148,000.00
$389,130,000.00
Revenue This Year
N/A
$31.33
Revenue Next Year
$4.35
$27.55
P/E Ratio
★ $28.45
$93.08
Revenue Growth
7.66
★ 33.94
52 Week Low
$25.81
$179.16
52 Week High
$43.14
$382.54

Technical Indicators

Market Signals
Indicator
TTEK
KRYS
Relative Strength Index (RSI) 36.05 41.98
Support Level $33.25 $331.79
Resistance Level $34.29 $371.16
Average True Range (ATR) 0.95 9.85
MACD -0.36 -1.37
Stochastic Oscillator 11.47 17.44

Price Performance

Historical Comparison
TTEK
KRYS

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: